Main clinical symptoms and stages of bronchial asthma diagnostics in adult patients


DOI: https://dx.doi.org/10.18565/therapy.2020.2.107-113

Ushakova D.V., Nenasheva N.M., Avtandilov A.G.

1 Polyclinic No. 1 of the Office of the President of the Russian Federation, Moscow; 2 Russian medical Academy of continuing professional education of the Ministry of Healthcare of Russia, Moscow
Asthma is a socially significant, widespread disease. Statistical data on the prevalence of asthma are significantly different from epidemiological studies, which is associated with under-diagnosis of this pathology. There is a significant deficit in the detection patients between registered and true morbidity. Therefore, the diagnosis of asthma, especially at an early stage of the disease, remains an urgent problem. There is a need to increase the level of knowledge in this area, especially for General practitioners. The purpose of compiling a diagnostic algorithm for asthma is to provide methodological assistance to doctors who are not specialists of allergology and pulmonology. The algorithm is based on modern international and federal recommendations for the diagnosis of asthma. The implementation of the diagnostic algorithm in the work of primary care physicians will help to increase the level of diagnosis of asthma at an early stage of the disease, and reduce the number of unverified cases of the disease.
Keywords: algorithm of diagnostic, clinical symptoms, asthma
Read entire article

Literature


  1. Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronicrespiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmo Dis. 2014; 9(1): 963–74. doi: 10.2147/COPD.S67283/

  2. Ильина Н.И., Ненашева Н.М., Авдеев С.Н. с соавт. Алгоритм биофенотипирования и выбор таргетнойтерапии тяжелой неконтролируемой бронхиальной астмы с эозинофильным типом воспаления дыхательных путей. Российский аллергологический журнал. 2017; 14(3): 5–18. [Ilina N.I., Nenasheva N.M., Avdeev S.N. et al. Algorithm of biophenotyping and choice of medication for targeted therapy of severe uncontrolled asthma with eosinophilic type of airways inflammation. Rossiyskiy allergologicheskiy zhurnal. 2017; 14(3): 5–18 (In Russ.)].

  3. Клинические рекомендации по бронхиальной астме, 2019 г. Утверждены Российским респираторным обществом, Российской ассоциацией аллергологов и клинических иммунологов, Союзом Ппдиатров России. Режим доступа: https://raaci.ru/dat/pdf/project_BA_2019.pdf (дата обращения 20.02.2020). [Clinical guidelines on management of asthma, 2019. Approved by Russian Association of Allergology and Clinical Immunology, National Medical Association of E.N.T., Union of Pediatricians of Russia. Available at: https://raaci.ru/dat/pdf/project_BA_2019.pdf (reference date 20.02.2020) (In Russ.)].

  4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019. Available at: www.ginasthma.org (reference date 21.02.2020)

  5. Parsons J.P., Hallstrand T.S., Mastronarde J.G. et al. An official American Thoracic Society clinical practice guideline: exercise induced bronchoconstriction. Am J Respir Crit Care Med. 2013; 187: 1016–27. doi: 10.1164/rccm.201303-0437ST.

  6. Diagnosis and Management of Difficult-to-treat and Severe Asthma in adolescent and adult patients. A GINA pocket guide for health professionals. April 2019, v 2.0. Available at: www.ginasthma.org (reference date 14.12.2019).

  7. Haccuria A., Michils A., Michiels S., Van Muylem A. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes. J Allergy Clin Immunol. 2014; 134: 554–59. doi: 10.1016/j.jaci.2013.12.1070.

  8. Dweik R.A., Boggs P.B., Erzurum S.C. et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 2011; 184(5): 602–15. doi: 10.1164/rccm.9120-11ST.

  9. Общая заболеваемость взрослого населения России в 2014 г. Министерство здравоохранения Российской Федерации. Департамент мониторинга, анализа и стратегического развития здравоохранения ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России. Статистические материалы, ч. IV. Москва, 2015 г. [Morbidity of the total adult population of Russia in 2014. The Ministry of Healthcare of Russia. Department of monitoring, analysis and strategic development of Healthcare of Central scientific research Institute of organization and informatization of Healthcare of the Ministry Healthcare of Russia. Statistical materials. Part IV. Moscow, 2015 (In Russ.)].

  10. Общая заболеваемость взрослого населения России в 2016 г. Министерство здравоохранения Российской Федерации. Департамент мониторинга, анализа и стратегического развития здравоохранения ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России. Статистические материалы, ч. IV. Москва, 2017 г. [Morbidity of the total adult population of Russia in 2016. The Ministry of Healthcare of Russia. Department of monitoring, analysis and strategic development of Healthcare of Central scientific research Institute of organization and informatization of Healthcare of the Ministry Healthcare of Russia. Statistical materials. Part IV. Moscow, 2017 (In Russ.)].

  11. Общая заболеваемость взрослого населения России в 2017 г. Министерство здравоохранения Российской Федерации. Департамент мониторинга, анализа и стратегического развития здравоохранения ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России. Статистические материалы, ч. IV. Москва, 2018 г. [Morbidity of the total adult population of Russia in 2017. The Ministry of Healthcare of Russia. Department of monitoring, analysis and strategic development of Healthcare of Central scientific research Institute of organization and informatization of Healthcare of the Ministry Healthcare of Russia. Statistical materials. Part IV. Moscow, 2018 (In Russ.)].


About the Autors

Dina V. Ushakova, head of the Department of allergology and immunology, pulmonology and infectious diseases, allergologist-immunologist of Polyclinic No. 1 of the Office of the President of the Russian Federation. Address: 119002, Moscow, 26/28 per. Sivtsev Vrazhek Str. Tel.: +7 (499) 241-74-47. E-mail: d.ushakova@vipmed.ru.
ORCID: https://orcid.org/0000-0003-4401-612X.
Natalya M. Nenasheva, MD, professor, head of the Department of allergology and immunology of Russian Medical Academy of continuing professional education of the Ministry of Healthcare of Russia. Address: 125993, Moscow, 2/1, build 1 Barrikadnaya Str. Tel.: +7 (495) 685-13-95. E-mail: allergy@rmapo.ru; 1444031@gmail.com.
ORCID: https://orcid.org/0000-0002-3162-2510.
Alexander G. Avtandilov, MD, professor, head of the Department of therapy and adolescent medicine of Russian Medical Academy of continuing professional education of the Ministry of Healthcare of Russia. Address: 125993, Moscow, 2/1, build.1 Barrikadnaya Str. Tel.: +7 (495) 484-94-75. E-mail: terpomed@mail.ru


Similar Articles

Back to Content

Бионика Медиа